King Investment Advisors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-144,830
Closed -$4.99M 122
2014
Q4
$4.99M Sell
144,830
-137,845
-49% -$4.5M 2.22% 17
2014
Q3
$8.44M Buy
282,675
+34,610
+14% +$734K 3.84% 3
2014
Q2
$4.98M Buy
248,065
+32,265
+15% +$740K 2.12% 20
2014
Q1
$5.87M Sell
215,800
-97,090
-31% -$2.58M 2.69% 14
2013
Q4
$6.49M Sell
312,890
-132,095
-30% -$2.49M 2.96% 10
2013
Q3
$8.1M Sell
444,985
-46,480
-9% -$840K 3.49% 1
2013
Q2
$8.17M Buy
+491,465
New +$7.85M 3.39% 5

Other funds holding AUXL

King Investment Advisors's AUXL Position: Q1 2015 in Review

King Investment Advisors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 144,830 shares — an estimated $4.99M sold.

King Investment Advisors first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $8.44M in Q3 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • King Investment Advisors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • King Investment Advisors sold 144,830 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $4.99M.
  • King Investment Advisors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • King Investment Advisors's AUXILIUM PHARAMCEUTICALS INC position peaked at $8.44M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on King Investment Advisors's 13F filing for Q1 2015, filed 15 May 2015.